To explore this idea, we reanalyzed six NEUROD2 and NEUROG2 induction experiments across diverse cell types, including embryonic stem cells (ESCs), P19 carcinoma cells and embryonic fibroblasts. This evidence concerns the gene NEUROD2 and carcinoma.